Trends of non-melanoma skin cancer incidence in Hong Kong and projection up to 2030 based on changing demographics

Abstract Objective To assess the trends in non-melanoma skin cancer (NMSC) incidence in Hong Kong from 1990 to 2019 and the associations of age, calendar period, and birth cohort, to make projections to 2030, and to examine the drivers of NMSC incidence. Methods We assessed the age, calendar period, and birth cohort effects of NMSC incidence in Hong Kong between 1990 and 2019 using an age-period-cohort model. Using Bayesian age-period-cohort analysis with integrated nested Laplace approximations, we projected the incidence of NMSC in Hong Kong to 2030. Results From 1990 to 2019, the age-standardized incidence rate of NMSC increased from 6.7 per 100,000 population to 8.6 per 100,000 population in men and from 5.4 per 100,000 to 5.9 per 100,000 population in women, among the 19,568 patients in the study (9812 male patients [50.14%]). The annual net drift was 2.00% (95% confidence interval [CI]: 1.50–2.50%) for men and 1.53% (95% CI: 0.95–2.11%) for women. Local drifts increased for both sexes above the 35–39-year age group. The period and cohort risk of developing NMSC tended to rise but slowed gradually in the most recent period and post-1975 birth cohort. From 2019 to 2030, it is projected that the number of newly diagnosed NMSC cases in Hong Kong will increase from 564 to 829 in men and from 517 to 863 in women. Population aging, population growth, and epidemiologic changes contributed to the increase in incident NMSCs, with population aging being the most significant contributor. Conclusion The slowing of the period and cohort effects suggests that the rising incidence of NMSC is partly attributable to increased awareness and diagnosis. The increasing prevalence of NMSC among the elderly and an aging population will significantly impact the clinical workload associated with NMSC for the foreseeable future.

[1]  World Population Prospects 2022 , 2022, Statistical Papers - United Nations (Ser. A), Population and Vital Statistics Report.

[2]  J. Bongaarts,et al.  United Nations Department of Economic and Social Affairs, Population Division World Family Planning 2020: Highlights, United Nations Publications, 2020. 46 p. , 2020 .

[3]  A. Karch,et al.  An R package for an integrated evaluation of statistical approaches to cancer incidence projection , 2020, BMC Medical Research Methodology.

[4]  D. Llewellyn,et al.  Insufficient Sun Exposure Has Become a Real Public Health Problem , 2020, International journal of environmental research and public health.

[5]  D. Schwebel,et al.  Population ageing and mortality during 1990–2017: A global decomposition analysis , 2020, PLoS medicine.

[6]  G. Patton,et al.  Time Trends in Cardiovascular Disease Mortality Across the BRICS , 2020, Circulation.

[7]  Ningli Wang,et al.  Significance of Outdoor Time for Myopia Prevention: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials , 2019, Ophthalmic Research.

[8]  D. Schwebel,et al.  A new method to attribute differences in total deaths between groups to population size, age structure and age-specific mortality rate , 2019, PloS one.

[9]  C. Moore,et al.  Nonmelanoma Skin Cancer. , 2019, Facial plastic surgery clinics of North America.

[10]  Elizabeth Lazaridou,et al.  Epidemiological trends in skin cancer , 2017, Dermatology practical & conceptual.

[11]  A. Ascherio,et al.  Serum levels of 25-hydroxyvitamin D and risk of multiple sclerosis among women in the Finnish Maternity Cohort. , 2017 .

[12]  R. Weller The health benefits of UV radiation exposure through vitamin D production or non-vitamin D pathways. Blood pressure and cardiovascular disease , 2017, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[13]  Leonhard Held,et al.  Projecting the future burden of cancer: Bayesian age–period–cohort analysis with integrated nested Laplace approximations , 2017, Biometrical journal. Biometrische Zeitschrift.

[14]  Xavier Castellsagué,et al.  Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches , 2017, Dermatology and Therapy.

[15]  A. Marghoob,et al.  Burden of basal cell carcinoma in USA. , 2015, Future oncology.

[16]  S. Feldman,et al.  Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. , 2015, JAMA dermatology.

[17]  Andrew E Moran,et al.  Demographic and epidemiologic drivers of global cardiovascular mortality. , 2015, The New England journal of medicine.

[18]  R. Weller,et al.  Ultraviolet Radiation Suppresses Obesity and Symptoms of Metabolic Syndrome Independently of Vitamin D in Mice Fed a High-Fat Diet , 2014, Diabetes.

[19]  T. Littlejohns,et al.  Vitamin D and the risk of dementia and Alzheimer disease , 2014, Neurology.

[20]  P. Rosenberg,et al.  A Web Tool for Age–Period–Cohort Analysis of Cancer Incidence and Mortality Rates , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[21]  O. Franco,et al.  Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies , 2014, BMJ : British Medical Journal.

[22]  S. Mohr,et al.  Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. , 2014, Anticancer research.

[23]  Randy Gordon,et al.  Skin cancer: an overview of epidemiology and risk factors. , 2013, Seminars in oncology nursing.

[24]  Christopher Gillberg,et al.  Vitamin D and autism: clinical review. , 2012, Research in developmental disabilities.

[25]  J. Leonardi-Bee,et al.  A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.

[26]  S. Feldman,et al.  The economic impact of non-melanoma skin cancer: a review. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[27]  E. Giovannucci,et al.  Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. , 2007, American journal of preventive medicine.

[28]  A. Ascherio,et al.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.

[29]  E. Kliewer,et al.  Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. , 2005, Journal of the American Academy of Dermatology.

[30]  A. Burd,et al.  Non-melanoma skin cancer in Hong Kong. , 2001, Hong Kong medical journal = Xianggang yi xue za zhi.

[31]  M A Weinstock,et al.  Nonmelanoma skin cancer in the United States: incidence. , 1994, Journal of the American Academy of Dermatology.

[32]  S. Frankel,et al.  Non-melanoma Skin Cancer , 2021, Surgical Oncology Manual.

[33]  C. Garbe,et al.  Epidemiology of Skin Cancer: Update 2019. , 2020, Advances in experimental medicine and biology.